Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sacral Neuromodulation With InterStim II in Neurogenic Bladder and/or Bowel Patients

NCT05688644 is registered in ClinicalTrials.gov with Omri Schwarztuch Gildor as lead sponsor.

NCT NCT05688644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sacral Neuromodulation With InterStim II in Neurogenic Bladder and/or Bowel Patients
Lead sponsor
Omri Schwarztuch Gildor
Phase
Observational
Overall status
Unknown status
Start date
December 19, 2021
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence, neurogenic bladder, neurogenic bowel, overactive bladder, retention, urinary, urge incontinence